These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36921632)

  • 1. Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease.
    Isshiki T; Vierhout M; Naiel S; Ali P; Yazdanshenas P; Kumaran V; Yang Z; Dvorkin-Gheva A; Rullo AF; Kolb MRJ; Ask K
    Biochem Pharmacol; 2023 May; 211():115501. PubMed ID: 36921632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.
    Lescoat A; Lelong M; Jeljeli M; Piquet-Pellorce C; Morzadec C; Ballerie A; Jouneau S; Jego P; Vernhet L; Batteux F; Fardel O; Lecureur V
    Biochem Pharmacol; 2020 Aug; 178():114103. PubMed ID: 32562787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality.
    Tsitoura E; Trachalaki A; Vasarmidi E; Mastrodemou S; Margaritopoulos GA; Kokosi M; Fanidis D; Galaris A; Aidinis V; Renzoni E; Tzanakis N; Wells AU; Antoniou KM
    Front Immunol; 2021; 12():645548. PubMed ID: 34867934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progress on the role and mechanism of 5-hydroxytryptamine and M2 macrophages in pulmonary interstitial fibrosis].
    Deng Y; Deng C; Zhu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Sep; 35(9):1004-1008. PubMed ID: 37803964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.
    Collins BF; Raghu G
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31578210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study.
    Guler SA; Machahua C; Geiser TK; Kocher G; Marti TM; Tan B; Trappetti V; Ryerson CJ; Funke-Chambour M
    Respir Res; 2022 Jun; 23(1):149. PubMed ID: 35676709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital quantification of p16-positive foci in fibrotic interstitial lung disease is associated with a phenotype of idiopathic pulmonary fibrosis with reduced survival.
    Keow J; Cecchini MJ; Jayawardena N; Zompatori M; Joseph MG; Mura M
    Respir Res; 2022 Jun; 23(1):147. PubMed ID: 35672770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases.
    Isshiki T; Naiel S; Vierhout M; Otsubo K; Ali P; Tsubouchi K; Yazdanshenas P; Kumaran V; Dvorkin-Gheva A; Kolb MRJ; Ask K
    Pharmacol Ther; 2024 Jan; 253():108578. PubMed ID: 38103794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
    Craig VJ; Zhang L; Hagood JS; Owen CA
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoengineered immunosuppressive therapeutics modulating M1/M2 macrophages into the balanced status for enhanced idiopathic pulmonary fibrosis therapy.
    Chang X; Xing L; Wang Y; Zhou TJ; Shen LJ; Jiang HL
    Nanoscale; 2020 Apr; 12(16):8664-8678. PubMed ID: 32227023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis.
    Herrmann FE; Wollin L; Wirth J; Gantner F; Lämmle B; Wex E
    Br J Pharmacol; 2017 Nov; 174(21):3848-3864. PubMed ID: 28810065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
    Lamb YN
    Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
    Feng H; Zhao Y; Li Z; Kang J
    Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus ameliorates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via JAK2/STAT3 signaling.
    Liu B; Jiang Q; Chen R; Gao S; Xia Q; Zhu J; Zhang F; Shao C; Liu X; Li X; Zhou H; Yang C; Huang H
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109424. PubMed ID: 36461589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Pro-Fibrotic Macrophage Populations by Single-Cell Transcriptomic Analysis in West Highland White Terriers Affected With Canine Idiopathic Pulmonary Fibrosis.
    Fastrès A; Pirottin D; Fievez L; Tutunaru AC; Bolen G; Merveille AC; Marichal T; Desmet CJ; Bureau F; Clercx C
    Front Immunol; 2020; 11():611749. PubMed ID: 33384697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary 5-HT
    Löfdahl A; Nybom A; Wigén J; Dellgren G; Brunnström H; Wenglén C; Westergren-Thorsson G
    Acta Histochem; 2023 Apr; 125(3):152024. PubMed ID: 36958084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasticity towards Rigidity: A Macrophage Conundrum in Pulmonary Fibrosis.
    Sari E; He C; Margaroli C
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease.
    Zhang J; Wang D; Wang L; Wang S; Roden AC; Zhao H; Li X; Prakash YS; Matteson EL; Tschumperlin DJ; Vassallo R
    Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L487-L497. PubMed ID: 30604628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Methodological Approach to Identify Natural Compounds with Antifibrotic Activity and the Potential to Treat Pulmonary Fibrosis Using Single-Cell Sequencing and Primary Human Lung Macrophages.
    Apte SH; Groves PL; Tan ME; Lutzky VP; de Silva T; Monteith JN; Yerkovich ST; O'Sullivan BJ; Davis RA; Chambers DC
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D In Vitro Models: Novel Insights into Idiopathic Pulmonary Fibrosis Pathophysiology and Drug Screening.
    Vazquez-Armendariz AI; Barroso MM; El Agha E; Herold S
    Cells; 2022 May; 11(9):. PubMed ID: 35563831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.